Table 1.
Transcription factors most abundantly regulated during osteoblast differentiation
| Gene | Full name | Fold change |
| Increased | ||
| DGSI | DiGeorge syndrome critical region gene | 7.10 |
| ZNF177 | Zinc-finger protein 177 | 5.77 |
| NCOR2 | Nuclear receptor co-repressor 2 | 4.92 |
| CRABP1 | Cellular retinoic acid binding protein 1 | 4.29 |
| IRX2A | Iroquois-class homeobox protein | 3.84 |
| NR1H2 | Nuclear receptor subfamily 1, group H, member 2 | 3.65 |
| GATA1 | Globin transcription factor 1 | 3.40 |
| POU2F1 | POU domain, class 2, transcription factor 1 | 3.16 |
| MAD4 | Mad4 homolog | 3.08 |
| ZNF143 | Zinc-finger protein 143 (clone pHZ-1) | 3.08 |
| ZNF133 | Zinc-finger protein 133 (clone pHZ-13) | 3.07 |
| SHOX2 | Short stature homeobox 2 | 3.01 |
| Decreased | ||
| MYC | v-Myc homolog | 5.00 |
| ZNF6 | Zinc-finger protein 6 | 3.57 |
| CA150 | Transcription factor CA150 | 3.33 |
| TCEB1 | Transcription elongation factor B (Elongin C) | 3.23 |
The data are from the microarray study of Qi et al. [12] and fold change describes the relative expression of the given factor in osteoblasts relative to expression in the mesenchymal progenitor cells.